Skip to main content
logo
Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
15.25
-0.57 (-3.60%)
At close: Jul 17, 2026, 4:00 PM EDT
15.11
-0.14 (-0.92%)
After-hours: Jul 17, 2026, 6:16 PM EDT

Anika Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
203133237332433517
Market Cap Growth
26.42%-43.75%-28.57%-23.26%-16.34%-20.22%
Enterprise Value
187.63100.19205.67289.37375.39442.28
Last Close Price
15.259.6116.4622.6629.6035.83
PE Ratio
----197.33127.96
Forward PE
66.3053.3939.1972.0872.08112.55
PEG Ratio
6.6311.401.963.603.60161.40
PS Ratio
1.751.181.982.753.803.50
PB Ratio
1.520.931.541.571.521.80
P/TBV Ratio
1.751.031.681.642.152.66
P/FCF Ratio
195.2930.60---159.01
P/OCF Ratio
31.3511.9343.92-98.1961.62
EV/Sales Ratio
1.610.891.722.403.302.99
EV/EBITDA Ratio
--68.1019.2120.6718.90
EV/EBIT Ratio
---342.86102.29169.13
EV/FCF Ratio
180.5822.97---135.92
Debt / Equity Ratio
0.180.170.160.120.100.07
Debt / EBITDA Ratio
--7.951.721.590.82
Debt / FCF Ratio
22.905.55---5.91
Net Debt / Equity Ratio
-0.13-0.23-0.20-0.20-0.20-0.26
Net Debt / EBITDA Ratio
2.576.25-10.47-2.84-3.17-3.21
Net Debt / FCF Ratio
-16.58-7.6313.565.9418.69-23.09
Asset Turnover
0.630.570.510.390.330.41
Inventory Turnover
2.312.301.821.191.071.58
Quick Ratio
3.193.713.403.064.334.17
Current Ratio
4.464.724.885.266.075.66
Return on Equity (ROE)
-7.99%-6.71%-4.82%-1.38%0.77%1.48%
Return on Assets (ROA)
-7.16%-6.03%-6.88%-0.30%0.54%1.25%
Return on Invested Capital (ROIC)
-11.67%-10.19%-11.17%-0.46%0.85%2.19%
Return on Capital Employed (ROCE)
-7.50%-6.35%-2.43%0.30%1.15%0.81%
Earnings Yield
----0.51%0.78%
FCF Yield
0.51%3.27%---0.63%
Buyback Yield / Dilution
3.24%2.59%-0.44%0.89%-1.05%-2.90%
Total Shareholder Return
3.24%2.59%-0.44%0.89%-1.05%-2.90%
SEC Filings: 10-K · 10-Q